Current sample size conventions: Flaws, harms, and alternatives
暂无分享,去创建一个
[1] Stephen J Senn,et al. Power is indeed irrelevant in interpreting completed studies , 2002, BMJ : British Medical Journal.
[2] D. Heisey,et al. The Abuse of Power , 2001 .
[3] Peter Bacchetti,et al. Peer review of statistics in medical research: the other problem , 2002, BMJ : British Medical Journal.
[4] S. Goodman,et al. p values, hypothesis tests, and likelihood: implications for epidemiology of a neglected historical debate. , 1993, American journal of epidemiology.
[5] Invited commentary: ethics and sample size--another view. , 2005, American journal of epidemiology.
[6] J. Manson,et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. , 2006, JAMA.
[7] Caroline A Crowther,et al. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population based study , 2006, BMJ : British Medical Journal.
[8] A S Detsky,et al. Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials. , 1990, Statistics in medicine.
[9] Gordon H Guyatt,et al. In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? , 2008, PLoS medicine.
[10] C. McCulloch,et al. Bacchetti et al. Respond to “Ethics and Sample Size—Another View” , 2005 .
[11] D. Horrobin. Are large clinical trials in rapidly lethal diseases usually unethical? , 2003, The Lancet.
[12] D. Moher,et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.
[13] J. Tukey. Tightening the clinical trial. , 1993, Controlled clinical trials.
[14] J. Manson,et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. , 2006, JAMA.
[15] Pre-publication history , 2001 .
[16] K. Schulz,et al. Sample size calculations in randomised trials: mandatory and mystical , 2005, The Lancet.
[17] A. Vail. Experiences of a biostatistician on a U.K. Research Ethics Committee. , 1998, Statistics in medicine.
[18] N. Breslow. Are Statistical Contributions to Medicine Undervalued? , 2003, Biometrics.
[19] H. Kraemer,et al. Caution regarding the use of pilot studies to guide power calculations for study proposals. , 2006, Archives of general psychiatry.
[20] D. Moher,et al. CONSORT statement requires closer examination , 2002, BMJ : British Medical Journal.
[21] S. Goodman,et al. The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.
[22] J. Matthews,et al. Small clinical trials: are they all bad? , 1995, Statistics in medicine.
[23] Andrew J Vickers,et al. Underpowering in randomized trials reporting a sample size calculation. , 2003, Journal of clinical epidemiology.
[24] Stephen Senn,et al. Statistical Issues in Drug Development , 1997 .
[25] C. McCulloch,et al. Ethics and sample size. , 2005, American journal of epidemiology.
[26] M. Gardner,et al. Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.
[27] Mark R. Segal,et al. Rejoinder for Discussions of "Simple, Defensible Sample Sizes Based on Cost Efficiency" , 2008 .
[28] Andrew R Willan,et al. The value of information and optimal clinical trial design , 2005, Statistics in medicine.
[29] M. Zwarenstein. Peer review of statistics in medical research , 2002, BMJ : British Medical Journal.
[30] J. Manson,et al. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial , 2022 .
[31] Philippe Ravaud,et al. Reporting of sample size calculation in randomised controlled trials: review , 2009, BMJ : British Medical Journal.
[32] J. Karlawish,et al. The continuing unethical conduct of underpowered clinical trials. , 2002, JAMA.
[33] D. Botstein,et al. Proposed Changes for NIH's Center for Scientific Review , 1999, Science.
[34] David Moher,et al. Peer review of statistics in medical research. Reporting power calculations is important. , 2002, BMJ.
[35] David Braunholtz,et al. Why “underpowered” trials are not necessarily unethical , 1997, The Lancet.
[36] M. Segal,et al. Simple, Defensible Sample Sizes Based on Cost Efficiency , 2008, Biometrics.
[37] Andrew R Willan,et al. Optimal sample size determinations from an industry perspective based on the expected value of information , 2008, Clinical trials.
[38] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.